DrugDev Teams with CISCRP and SCRS to Present Educational Webinars Highlighting the Patient-Friendly Benefits of eConsent

Share Article

Find out how eConsent improves patient comprehension and engagement

Eric Delente, DrugDev President, Patient Solutions

At these webinars expert speakers will provide background on the purpose of eConsent and its ability to improve patient engagement and comprehension.

This month, DrugDev makes the case for continued sponsor adoption of eConsent solutions through webinars with The Center for Information and Study on Clinical Trial Participation (CISCRP) and the Society for Clinical Research Sites (SCRS). Experts will provide background on the purpose of eConsent and the ability for eConsent to improve patient engagement and comprehension.

Statistics show an average of 18% to 30% of patients enrolling in a clinical study will drop out, with at least 13% of drop-outs attributed to patient misunderstanding of consent expectations and the clinical trials process. This sad statistic is costly yet preventable, and these webinars will demonstrate how a patient-focused consent process can reduce the number of drop outs and improve consent effectiveness for all including investigators, sponsors, sites – and most importantly, patients.

The CISCRP webinar is focused on patients, and the SCRS webinar on sites. Both webinars will provide information for stakeholders interested in improving patient satisfaction. Learn more and register for the sessions below.

CISCRP Webinar: Improve Patient Comprehension, Engagement, and Retention with eConsent
Webinar Date: Thursday, June 15, 2017
Time: 12:00-1:00 PM ET
Presenter: Ken Getz | CISCRP - Eric Delente | DrugDev
Registration: Register Here
(Free for all attendees)

Ken Getz, Founder of CISCRP and Director of Sponsored Research Programs and Associate Professor at Tufts CSDD, Tufts University School of Medicine will discuss the purpose of informed consent, rules and regulations around the informed consent process, and share data and insights from the patient perspective. eConsent expert Eric Delente, President of DrugDev Patient Solutions, will show webinar attendees how this revolutionary technology benefits pharma sponsors, CROs, sites and patients.

SCRS Webinar: How Sites Can Drive Patient Retention with eConsent
Webinar Date: June 27, 2017
Time: 12:00-1:00 PM ET
Presenter: Eric Delente | DrugDev
Registration: Register Here
(Free for SCRS members, $79.00 for non-members)

Eric Delente will demonstrate the benefits of eConsent for clinical trial sites. He will identify how eConsent increases patient understanding and retention rates, while addressing sites’ “fear of change” and implementation concerns, and identifying how eConsent increases site performance.

About SCRS
SCRS is a global trade organization founded in 2012 which represents over 4,000 research sites in over 45 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Our Voice. Our Community. Your Success. Join the community and collaborate with the global experts in site sustainability. Visit MySCRS.org.

The Center for Information and Study on Clinical Research Participation (CISCRP) is a 501(c)(3) non-profit organization dedicated to engaging the public and patients as partners in the clinical research process. CISCRP provides free education and outreach to the general public and patient communities. Visit http://www.CISCRP.org for more information or to support CISCRP’s educational initiatives.

About DrugDev
DrugDev helps the world do more trials through industry-wide collaboration, standardization and a beautiful technology experience. DrugDev Spark™, the unified clinical operations suite, is comprised of proven solutions used by 85 sponsors and CROs on over 1,800 clinical trials to transform the quality and efficiency of clinical trials from startup through closeout. DrugDev Spark is powered by the DrugDev Golden Number, the award-winning universal identifier for global site facilities and investigators used by TransCelerate and the Investigator Databank. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev by scheduling a demo of DrugDev Spark at drugdev.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brenda Nashawaty
+1 617-688-3253
Email >

Cindy Murray
Email >
Visit website